Haishan Li has 13 years of professional experience in the field of chemistry. In 2021, they began working as the Director of Chemistry at Hopewell Therapeutics Inc. Prior to this, they worked as a Senior Scientist II at Nitto Avecia from 2020-2021, during which they developed processes and methods for the synthesis, purification, ultrafiltration, lyophilization, and testing of oligonucleotides. From 2016-2020, they worked as a Principal Process Development Chemist at Perkin Elmer Inc., where they developed bioanalytical assay kits, including AlphaLISA, LANCE/DELFIA, and OPAL Multiplex IHC platforms. From 2008-2016, they worked as a Senior Scientist at PerkinElmer LAS. From 2007-2008, they worked as a Postdoc at UNC. From 2002-2007, they worked as a Postdoc Fellow at Albert Einstein Medical Center.
Haishan Li received their high school diploma from Lishui High School in 1989. haishan then attended Nanjing University, where they earned a B.S. in Chemistry in 1996. haishan then went on to Stony Brook University, where they received their Ph.D. in 2002.
November, 2021 - present
Director Of Chemistry Research And Process Development at CTC Global
Director Of Chemistry Manufacturing And Controls at Airway Therapeutics
Director of Chemistry at Orphagen Pharmaceuticals
Director Of Chemistry at MC Nutraceuticals
Director of Chemistry at Sygnature Discovery Limited
Access the worlds's biggest network of public org charts
Learn more